Navigation Links
CorVel Corporation Medical Provider Network Adds New Providers to Increase Savings and Improve Access to Care
Date:10/1/2007

IRVINE, Calif., Oct. 1 /PRNewswire-FirstCall/ -- CorVel Corporation (Nasdaq: CRVL), a leading provider of workers' compensation claims management services, announced the addition of over 150,000 facility and provider locations to its national CorCare Preferred Provider Network effective November 1, 2007. The new provider network additions are the result of a new partnership with Integrated Health Plan (IHP) headquartered in St. Petersburg, FL.

With more than 5,500 hospitals and over 637,000 physicians and ancillary facilities in their network, Integrated Health Plan is one of the nation's largest multi-specialty PPO networks. IHP is experienced in working with both self-insured and fully-insured clients of all sizes and is currently utilized by many of the largest payors and intermediaries in the group health, limited medical, workers'compensation and auto liability industries.

CorVel conducts periodic evaluations of its network performance customer savings in order to ensure the continuation of its industry-leading Network Solutions results. The cornerstone of CorVel's Network Solutions is CorVel's proprietary "First Review" artificial intelligence software engine. Investments are expected to continue to further expand the scope of this cutting edge tool. Most recently CorVel announced plans to extend its clearinghouse capabilities to its customers and providers. For several years CorVel has been involved in the acceptance and routing of electronic bills (ebills) in workers compensation. The technologies supporting the expanded use of its clearinghouse facilities include document conversion and tracking tools, ebill processing capabilities and "smart routing" capabilities first implemented three years ago
'/>"/>

SOURCE CorVel Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Trouble-shooting: Misincorporation or low fidelity
2. Roche Diagnostics Corporation
3. Roche Diagnostics Corporation
4. Promega Corporation: Wisconsins quiet innovator
5. Giuliani will keynote RedPrairie Corporations user conference
6. Madison Development Corporation makes loans to three area companies
7. Corporations and blogging
8. Metavante acquires Florida banking corporation
9. TriMas Corporations Cequent Group Acquires Chem-Chrome, Inc.
10. Medical College receives $377K to study brain disease
11. Barriers will not stop convergence of medical technologies

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)... 6 BioSpecifics Technolo...ompany developing first-in-class collagenase-based...or the third quarter ended September 30, 2009. ,... this year, the FDA,s Arthritis Advisory Committee...pproval of XIAFLEX(TM) for the treatment of Dupuyt...
(Date:11/6/2009)...., Nov. 6 Calbiotech, Inc. announc... Innovative Research (SBIR) Phase I contract by th... Under terms of the agreement, Calbiotech will dev...nosis of Dengue virus. ,, Dengue virus is a ...hreat to military forces deployed to tropical area...
(Date:11/5/2009)...ov. 5 GenVec, Inc. (Nasd...for the third quarter ended September 30, 2009. Ge...r share) for the three months ended September 30, ... per share) in the comparable quarter of 2008. For...s net loss was $14.1 million ($0.15 per share), co...
(Date:11/5/2009)...hursday, November 5, 2009 at 4:30 p.m. Eastern Tim...ire-FirstCall/ - OncoGenex Pharmaceuticals, Inc. (...ay reported unaudited financial results for the th...09 and reviewed the Company,s highlights for the t...ated results reflect the operations of OncoGenex T...
Breaking Biology Technology:Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 6Calbiotech Awarded U.S. Army Phase I SBIR Research Contract to Develop Analyte Specific Reagents for the Diagnosis of Dengue Fever Virus 2GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 2OncoGenex Reports Third Quarter 2009 Financial Results 3OncoGenex Reports Third Quarter 2009 Financial Results 4OncoGenex Reports Third Quarter 2009 Financial Results 5OncoGenex Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 7OncoGenex Reports Third Quarter 2009 Financial Results 8
...he,state stem cell agency by California,s Controll...t created the agency, Consumer Watchdog said today...iang found that with a,relatively minor exception ... (CIRM) complies with the requirements of Proposit... they relate to conflict-of-interest,policies, gra...
...of Financing for $3 Million, PITTSBURGH, May 12 ...athology, Inc.,s PathFinderTG(R) have fueled the,c...of-the-art headquarters,in Pittsburgh and the grow..., up from 20 a year ago. Against this backdrop, th...sider round of financing for $3 million. The,proce...
...Pink Sheets: MEDQ), the largest Medical Transcript...riday, May 9th, filed its Form 10-Q quarterly,repo...n for the quarter,ended March 31, 2008., Revenue ...with $89.1M,in the first quarter of 2007. The decr... period was primarily due to customer losses exper...
Other Biology Technology:Controller's Stem Cell Agency Audit Ignores California Agency's Built-in Flaws 2Controller's Stem Cell Agency Audit Ignores California Agency's Built-in Flaws 3Expansion and Relocation to New, State-Of-The-Art Facilities Marks Milestone in Effort to Roll Out New Tool for Cancer Diagnosis 2Expansion and Relocation to New, State-Of-The-Art Facilities Marks Milestone in Effort to Roll Out New Tool for Cancer Diagnosis 3MedQuist Reports First Quarter 2008 Results 2MedQuist Reports First Quarter 2008 Results 3MedQuist Reports First Quarter 2008 Results 4MedQuist Reports First Quarter 2008 Results 5MedQuist Reports First Quarter 2008 Results 6MedQuist Reports First Quarter 2008 Results 7MedQuist Reports First Quarter 2008 Results 8MedQuist Reports First Quarter 2008 Results 9
(Date:11/5/2009)... Conn.Researchers at Yale University have develope...y,s immune response to HIV and HIV-infected cells,...gs, published online in the Journal of the Americ...tic approaches for these diseases. , The molecu...g HIV" (ARM-H) and "antibody-recruiting molecule t...
(Date:11/4/2009)...(top news in natural science) , United States ... less water today than it did 35 years ago, despit...ter use are partly attributable to alternative coo...rigation systems. According to the latest USGS wat...e United States goes to cooling thermoelectric pow...
(Date:11/4/2009)... BC - Lowly bacteria, it turns out, hold the power...ants around the world clean up toxic waste on test...cally RDX, were invented back in World War II and ... These high-energy compounds are often used to pro...on of TNT. , But with increased knowledge of t...
Breaking Biology News(10 mins):New synthetic molecules trigger immune response to HIV and prostate cancer 2USGS science picks 2USGS science picks 3USGS science picks 4USGS science picks 5USGS science picks 6USGS science picks 7Genomic research will enable greener cleanup of military explosive test sites 2China Biotics Inc Announces Closing of Public Offering of Common Stock 58860 1China Biotics Inc Announces Closing of Public Offering of Common Stock 58860 2China Biotics Inc Announces Closing of Public Offering of Common Stock 58860 3VIDEO from Medialink and CIGNA 3A Dont Stress Out Over Stress Some of it is Good for You 58857 1VIDEO from Medialink and CIGNA 3A Dont Stress Out Over Stress Some of it is Good for You 58857 2Peregrine Pharmaceuticals Reports Positive Results From Phase II Bavituximab Lung Cancer Trial 14351 1Peregrine Pharmaceuticals Reports Positive Results From Phase II Bavituximab Lung Cancer Trial 14351 2Peregrine Pharmaceuticals Reports Positive Results From Phase II Bavituximab Lung Cancer Trial 14351 3Peregrine Pharmaceuticals Reports Positive Results From Phase II Bavituximab Lung Cancer Trial 14351 4
...nable part of the world,s energy future, especiall...ly abandoned or degraded agricultural lands, repor...nford University. Using these lands for energy cro...earing new land, avoids competition with food prod... to mitigate climate change. Sustainable bioenergy...
...ite near Pulborough, West Sussex, has thrown remar...ast Neanderthals. It provides a snapshot of a thri...es on the verge of extinction. , "The tools we,ve...d potentially older than tools in Britain belongin...ew Pope of Archaeology South East based at the UCL...
...Foundation for the Advancement of Military Medicin...he Health Sciences (USU) are holding the first-eve...researchers and clinicians to discuss current and ...WHAT: USU-HJF Symposium, Experts in their respecti...reaking work being undertaken within the DoD medic...
Other Biology News:Abandoned farmlands are key to sustainable bioenergy 2Britain's last Neanderthals were more sophisticated than we thought 2
GIBCO BGJb Medium (Fitton-Jackson Modification) (1X) liquid from Invitrogen
11(R)-HETE from Cayman Chemical
Rabbit Anti-T-box 6 Monoclonal Antibody, Unconjugated, Clone PADZMD.501 from Invitrogen
Rat Anti-karyopherin alpha2 Monoclonal Antibody, Unconjugated, Clone 2G7 from Santa Cruz Biotechnology, Inc.
Biology Products: